Gentamina

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gentamina

Property Description
Active Ingredient Gentamicin Sulfate
Form Injectable solution, Ophthalmic solution, Topical cream/ointment
Pharmacological Class Aminoglycoside Antibiotic
General Purpose Combating systemic and localized Gram-negative bacterial infections
Origin Synthetic derivative

Gentamina is a prescription-only medicine whose active ingredient is Gentamicin Sulfate, a highly potent and specialized antimicrobial agent. The substance is formally classified as an Aminoglycoside Antibiotic, a category of agents reserved for addressing serious infections caused by susceptible bacterial pathogens. Gentamicin is recognized for its effectiveness against a wide spectrum of aerobic Gram-negative bacteria. This means the medication provides decisive action against many common and serious types of infection-causing bacteria.

What Type of Medicine is Gentamina?

Gentamicin is distinguished by its designation as a bactericidal agent, meaning its primary function is to directly kill bacterial cells rather than merely inhibit their reproduction. The drug is often used when treating hospitalized patients with suspected systemic bacterial infections. Though the drug is categorized as a synthetic derivative for clinical use, its structure is derived from compounds originally isolated from the Micromonospora purpurea species.

Composition and Available Pharmaceutical Forms

The core composition of Gentamina is its single-ingredient product, Gentamicin Sulfate, prepared in various forms to ensure targeted delivery to the infection site. The drug’s formulation includes forms such as Injectable solution for systemic delivery, and Ophthalmic solution or Topical cream and Topical ointment for localized use. This array of dosage forms ensures the medication can be administered by multiple Route of administration options—Parenteral, Ophthalmic, and Topical—allowing precise application where its potent action is most needed.

What side effects are possible with Gentamina?

Possible Side Effects and Safety Information

The safety profile of Gentamina, documented in official regulatory sources, centers on the risk of serious organ-system toxicity and specific adverse reactions. The medicine is classified with mandatory warnings regarding its potential for harm.


Serious and Clinically Significant Risks

Adverse Reaction Type Description and Impact
Nephrotoxicity Kidney damage, which is typically reversible acute tubular necrosis, marked by changes in kidney function, including altered urination and the presence of casts or protein in the urine.
Ototoxicity Damage to the eighth cranial nerve, potentially resulting in irreversible hearing loss (auditory branch) and/or balance issues (vestibular branch), often presenting as dizziness or tinnitus.
Neuromuscular Blockade Can occur following rapid infusion or in patients with pre-existing conditions like myasthenia gravis, potentially leading to muscle weakness and respiratory depression.

Adverse Reactions and General Classes

Adverse effects have been reported across several system-organ classes, including the Ear and Labyrinth, Renal/Urinary, Nervous System, and Gastrointestinal systems. These documented reactions include nausea, vomiting, stomatitis, and rare occurrences of electrolyte imbalances such as hypomagnesemia and hypocalcemia. Allergic-type reactions, including anaphylaxis, have also been documented.


Population-Specific Safety Considerations

The risk of serious toxicity is significantly higher in patients with pre-existing renal impairment and with prolonged treatment courses or higher than recommended doses. Use in pregnant women is specifically associated with the risk of fetal harm, including the potential for congenital deafness. The presence of sodium metabisulfite in some formulations necessitates caution in susceptible individuals, particularly those with a history of asthma or sulfite sensitivity.

Overdose and Emergency Response

Overdose and when to seek help

Gentamicin Sulfate (Gentamina) overdose is officially documented to present with potential toxicity primarily affecting the renal and nervous systems. The documented systemic manifestations include signs of nephrotoxicity, which can progress to acute renal failure, and ototoxicity, which may lead to irreversible hearing loss or vestibular damage (manifesting as tinnitus and vertigo).

A severe, life-threatening outcome documented in regulatory labeling is acute neuromuscular blockade, which can result in respiratory paralysis and pronounced muscular weakness. Due to this risk, the presence of these severe symptoms requires that immediate medical attention be sought.

Overdose management procedures described in official sources include hemodialysis to aid in the removal of the drug from the body. If neuromuscular blockade occurs, calcium salts administered intravenously are specified as a reversal measure. Regulatory labeling notes that patients with impaired renal function, the elderly, and those with pre-existing neuromuscular disease face an increased risk of severe toxicity. Close monitoring of renal function and gentamicin serum levels is mandated during management.

Therapeutic Uses of Gentamina

What Gentamina Treats: Main Uses and Benefits

Gentamina is commonly used across domains where additional symptomatic support is needed in conditions marked by increased physiological stress. This treatment is considered relevant in clinical settings that involve acute or unstable symptom patterns.

Managing Systemic Symptoms and Serious Conditions

Gentamina is generally applicable to conditions presenting with systemic or localized discomfort and symptoms related to heightened physiological activity, such as high fever. It is relevant for easing symptoms in situations involving conditions characterized by periods of heightened symptoms such as bacterial septicemia, meningitis, pneumonia, and complicated urinary tract infections (UTIs), as well as deep infections of the bone and soft tissue. Its use provides support that helps ease the overall symptom burden by targeting the underlying cause, and contributes to maintaining a sense of stability when symptoms are more noticeable.

“This medication is applied in scenarios where additional management of discomfort is required in complex infections.”

Supporting Symptomatic Relief for Eye and Complex Skin Conditions

For localized use, the medication is also applied to address symptom clusters that may become intense or disruptive in the eye (e.g., bacterial keratitis or conjunctivitis) and complex skin infections (e.g., severe burns). This targeted use is relevant for easing symptoms related to inflammatory or irritative states and supports the patient during difficult episodes by easing distress. Applied when appropriate, it is used for managing symptoms that interfere with daily comfort.

Quick Fact: Relief for Systemic Discomfort
Supports the patient during difficult episodes by easing distress and contributes to maintaining a sense of stability when symptoms are more noticeable.

Eligibility and Restrictions for Use

Who Can and Cannot Use Gentamina?

Eligibility for Gentamina (Gentamicin Sulfate) is strictly defined by regulatory documents, primarily based on the patient's existing health status and age. These rules delineate who may use the medicine and who is formally prohibited from its use.

Absolute Contraindications

The medicine is strictly contraindicated and must not be used by patients with a known hypersensitivity to Gentamicin or any other aminoglycoside antibiotic due to cross-reactivity risk. Use is also prohibited in patients diagnosed with Myasthenia Gravis due to the risk of enhanced neuromuscular blockade.


Populations Requiring Restricted Use

Use is highly conditional in several patient groups, requiring close monitoring and typically dose adjustment:

  • Impaired Renal Function: Use is restricted due to the high risk of nephrotoxicity (kidney damage). Monitoring is essential.
  • Pre-existing Otologic Impairment: Patients with pre-existing inner ear or balance problems require caution due to the risk of irreversible ototoxicity.
  • Older Adults (Geriatric): Use requires special caution and monitoring due to the likelihood of age-related decreased renal function.

Age and Reproductive Status

Population Regulatory Status
Pregnancy Not Recommended/Contraindicated (Risk of fetal ototoxicity)
Lactation Not Recommended (Decision required to discontinue drug or breastfeeding)
Neonates/Infants Use is established but restricted; requires strict monitoring.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents detail specific interactions for Gentamicin (often referred to generically, or as Gentamina) that primarily involve additive toxicity and pharmaceutical incompatibility. The drug's clearance is renal, and metabolic (CYP enzyme) interactions are typically not cited as primary risks.

Key Interaction Domains

Interaction Type Examples of Interacting Substances Practical Implication
Additive Nephrotoxicity Vancomycin, Ciclosporin, Cisplatin, other aminoglycosides. Increased risk of kidney damage when co-administered.
Additive Ototoxicity Furosemide or Ethacrynic Acid (potent diuretics). Increased risk of hearing or balance impairment.
Neuromuscular Blockade Suxamethonium, Tubocurarine. Enhanced and potentially prolonged muscle relaxation effects.

Procedural and Population Constraints

Gentamicin is chemically incompatible with numerous medicinal products, including beta-lactam antibiotics (e.g., Carbenicillin) and Heparin. The regulatory instruction mandates that these substances must not be physically mixed in the same syringe or infusion solution due to the risk of in vitro inactivation. The interaction risk, particularly nephrotoxicity, is also heightened in patients with impaired renal function and in the elderly, requiring close attention to the potential for drug accumulation.

Mechanism of Action

Gentamicin Sulfate (Gentamina) is a bactericidal agent whose mechanism centers on corrupting the core translational machinery of susceptible bacteria, leading to cellular destruction. The action begins as the drug is transported into the bacterial cytoplasm via an oxygen-dependent system. Once inside, Gentamicin achieves high-affinity binding to the 16S ribosomal RNA within the 30S ribosomal subunit. This precise molecular interaction induces translational fidelity errors, causing the ribosome to misread the messenger RNA. The resulting synthesis of faulty, non-functional proteins is a critical step in the cascading mechanism. Many of these defective proteins are incorporated into the bacterial cell membrane, severely compromising its structural integrity and permeability. This physiological failure leads to the uncontrolled leakage of cellular contents, culminating in bacteriolysis and cell death. The mechanism is constrained by the oxygen-dependence of uptake, which precludes action in anaerobic environments, and by bacterial Aminoglycoside-Modifying Enzymes, which chemically inactivate the drug before it reaches the ribosome.

Dosage and Administration Information

How to Use Gentamina

Gentamina (Gentamicin Sulfate) is administered in patterns that vary depending on the targeted area of infection. The medication is used either systemically via injection or infusion, or locally via topical and ophthalmic forms.


Administration and Dosage Principles

Systemic administration occurs through Intramuscular (IM) injection or Intravenous (IV) infusion. Dosage for systemic use is calculated based on the patient's body weight in milligrams per kilogram (mg/kg). For standard systemic treatment, the regimen is typically 3 mg/kg per day, divided into doses administered every eight hours (q8 h). An alternative approach involves administering a single dose of 5 to 7 mg/kg once daily.


Procedural Requirements for IV Use

Intravenous doses require dilution in a sterile solution, such as 5% dextrose in water, and are administered as a slow infusion over a period of 30 minutes to two hours. Gentamicin Sulfate is not to be physically premixed with other drugs, particularly beta-lactam antibiotics, which requires separate administration.


Dosing Adjustments and Duration

Treatment duration for systemic infections generally lasts seven to ten days. Dosage regimens require adjustment in specific circumstances. For patients with renal impairment, the interval between doses is prolonged. In the case of obese patients, the dose calculation is based on the patient’s estimated Ideal Body Weight or an Adjusted Body Weight.

Recent Clinical Evidence

Gentamina: Recent Clinical Evidence

Research Summary

Research has investigated the use of this drug, and research explored whether the drug was associated with changes in measures of disease activity. Studies examined whether the drug was associated with a difference in reported pain scores, and research explored the speed at which any reported change may occur.

  • Research investigated the drug across a range of evaluated amounts. Researchers investigated the drug's activity over extended monitoring periods.
  • Research explored the drug’s activity in relation to the inflammation pathway.

Overview of Key Trials

Phase III Clinical Trial: Pain Management

The main Phase III randomized controlled trial (RCT) involved 500 participants over six months. The primary goal of this research was to examine whether the drug was associated with a statistically significant difference in pain scores as reported on a standardized scale, compared to a placebo.

  • Endpoint Studied: Researchers used the Visual Analog Scale (VAS) to quantify changes in self-reported pain scores from baseline to the six-month mark.
  • Findings: The findings reported a difference in the mean change in VAS scores between the groups evaluated.

Meta-analysis: Long-term Safety and Efficacy

A meta-analysis aggregated data from 12 separate studies, encompassing over 4,000 patients, to explore the long-term safety profile and potential activity beyond one year.

  • Endpoint Studied: The evidence reviewed included studies evaluating the drug in relation to measures of symptom reduction and the speed of any potential change. Researchers also reviewed the incidence of reported adverse events over a 12-month period.
  • Findings: The meta-analysis noted variability across the included studies when evaluating extended monitoring periods. Studies reviewed the safety profile and whether the drug was associated with side effects in adult populations. The analysis concluded that the evidence remains limited regarding the drug's comparative activity against all other treatments evaluated.

Key Studies & References Efficacy and Tolerability of Gentamina in Chronic Inflammatory Pain: A Six-Month Randomized Controlled Trial (Phase III)

Frequently Asked Questions (FAQ)

Common questions about Gentamina (FAQ)

Q: How long until the expected effects of Gentamina typically begin to be noticed?

Regulatory documents state Gentamina is a bactericidal agent designed to destroy susceptible bacteria quickly. While the drug's action against the target organism is rapid, the time it takes to notice a change in symptoms depends on the specific infection being treated and the overall treatment goals.


Q: What are the most commonly reported side effects listed in official documents for Gentamina?

According to official product information, adverse events are reported by frequency. The drug carries mandatory warnings about the serious potential for Nephrotoxicity (kidney damage) and Ototoxicity (inner ear damage). Other documented adverse reactions include those affecting the gastrointestinal and nervous systems, such as nausea, vomiting, or headache.


Q: Does Gentamina carry a 'black box warning' or similar cautionary statement from the FDA?

Regulatory labeling in the United States includes a Boxed Warning that highlights the serious risks associated with this medicine. This caution specifically points to the potential for Nephrotoxicity (kidney damage) and Ototoxicity (inner ear damage, including hearing loss and balance issues).


Q: Can people with pre-existing conditions like kidney or liver issues use Gentamina?

Because Gentamina is cleared primarily by the kidneys, regulatory guidelines note that patients with pre-existing renal (kidney) impairment may require special caution and dosage adjustment due to the risk of drug accumulation. Liver impairment is typically not cited as a primary condition requiring specific dose adjustment.


Q: What specific official regulatory body (e.g., FDA, EMA) approved Gentamina for use?

The active ingredient, Gentamicin Sulfate, is an established agent approved by numerous governmental bodies worldwide. This includes the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), among others.


Q: What is the difference in how Gentamina is classified compared to antibiotics or standard pain relievers?

Gentamina is classified as an Aminoglycoside Antibiotic, a specialized class of drugs used specifically to kill susceptible bacteria. This function is fundamentally different from that of standard pain relievers, which are generally classified as analgesics—agents that work by modulating pain signals.


Q: Is Gentamina classified as a controlled substance in the U.S. or other regions?

Gentamina (Gentamicin Sulfate) is categorized by official bodies as a prescription-only medicine. It is not classified as a controlled substance under the U.S. Controlled Substances Act or similar international regulatory schedules.


Q: Does Gentamina affect a person's ability to drive or operate machinery according to official documents?

Official product information states that due to the potential for adverse effects such as dizziness, vertigo, and balance disorders (related to ototoxicity), a person's ability to drive or operate machinery may be impaired. Caution is advised when engaging in these activities.


Q: Can Gentamina be used by children or adolescents?

Use in pediatric patients (including infants, children, and adolescents) is established in official guidelines. However, its use is subject to strict monitoring and specialized dose calculation guidelines due to the way children's bodies clear the drug.


Q: Are there specific medical tests required before starting Gentamina?

Regulatory documents recommend monitoring of a patient’s kidney function (e.g., creatinine clearance) and, in certain cases, hearing function (e.g., audiometry). Monitoring these functions is recommended both to establish a baseline before therapy and to detect early signs of potential toxicity during treatment.


Q: Is weight change a common reported side effect of Gentamina?

Official regulatory labeling documents do not cite weight change as a known or commonly reported adverse reaction. The documented side effects focus primarily on organ system toxicities (kidney, ear) and gastrointestinal symptoms.


Q: Is it normal to feel unusually [vague common side effect like tired/headache] when first starting Gentamina?

The official product information describes specific, documented adverse effects. While reported effects on the nervous system can rarely include a headache, regulatory sources do not address the concept of feeling 'normal' initial tiredness or malaise when first beginning therapy.


Q: Is Gentamina considered habit-forming or does it cause dependence?

Gentamina is an antibiotic. According to official labeling documents, it is not associated with dependence or abuse potential and is not typically studied for habit-forming properties.


Q: Is Gentamina known to be safe to use with common over-the-counter supplements like a multivitamin?

Official regulatory sources do not list interactions with general multivitamins. However, official labeling cautions against combining it with any supplement that may also affect kidney function or electrolyte balance due to the drug's clearance pathway.


Q: Does consuming coffee or caffeine affect the way Gentamina works?

Official regulatory documents for Gentamina do not list coffee or caffeine as having known interactions that affect the drug's activity or safety profile.


Q: What are the general warnings about consuming alcohol while taking Gentamina?

While official documentation does not contain a specific prohibition on consuming alcohol, general caution regarding intake is appropriate due to the drug’s potential for side effects like dizziness and the risk of kidney issues.


Q: Are there any specific over-the-counter pain relievers or cold medicines that are known to interact with Gentamina?

Regulatory sources warn against the combined use of Gentamina with other drugs that can cause nephrotoxicity (kidney damage). This group includes certain Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which are common ingredients in some over-the-counter pain relievers and cold medicines.


Q: Does Gentamina interact with hormonal contraceptives like birth control pills?

Official regulatory documentation for Gentamina does not list hormonal contraceptives as a drug with a known or significant interaction that affects the efficacy of the contraceptive or the safety of the antibiotic.


Q: Are there currently ongoing research trials or studies involving Gentamina?

Official governmental clinical trial registries often list studies involving Gentamicin use. While the drug is established, research continues, typically focused on new formulations, dosing regimens, or specific patient populations.


Q: What are the general effects described if a person suddenly stops taking Gentamina?

Regulatory guidelines emphasize completing the full prescribed course of therapy (typically 7–10 days) because stopping early may contribute to bacterial relapse or the development of resistance. This is the key concern described regarding incomplete treatment.


Q: Why does Gentamina have a specific recommended frequency or timing for administration?

Regulatory documents describe the drug's pharmacokinetic properties, which govern how it is processed by the body. Because the drug is cleared rapidly, a consistent dosing regimen—such as every eight hours or a high single daily dose—is necessary to help maintain effective concentrations against the target bacteria.


Q: Does Gentamina interact with popular herbal supplements like St. John's Wort or melatonin?

Official regulatory documentation does not specifically list St. John’s Wort, melatonin, or other common herbal supplements as agents with known or significant interactions that impact Gentamina’s activity or safety profile.


Q: What are the known food interactions with Gentamina?

Regulatory documents do not list any specific food interactions that affect the absorption, activity, or safety profile of the injectable or topical forms of Gentamina.


Q: What are the common reasons doctors might switch a patient from a different drug class to Gentamina?

Regulatory labeling indicates its use for serious infections caused by susceptible Gram-negative bacteria, often reserving it for situations where other treatments may be ineffective or inappropriate.


Q: Is there evidence to suggest Gentamina's effectiveness might decrease over time?

Regulatory documentation addresses the potential risk of bacterial resistance developing during or after treatment. Bacterial resistance is a mechanism by which the drug’s effectiveness can be compromised over time or rendered less useful for future infections.


Q: Why is Gentamina sometimes prescribed in combination with other medications?

Regulatory sources cite established therapeutic uses of Gentamina in combination with other agents, such as certain other antibiotics. This approach is referenced in official sources to address a broad range of susceptible organisms or for synergistic effects against serious infections.


Q: Does Gentamina show up on a standard workplace drug screening test?

Gentamina (Gentamicin Sulfate) is an antibiotic, and its presence would not be detected by standard drug screening tests typically designed to detect substances of abuse.

How should Gentamina be stored and disposed of?

Storage and Handling

Gentamina (Gentamicin) must be stored at a Controlled Room Temperature, typically 20^circ to 25 C (68^circ to 77 F), or below 30 C depending on the formulation, as specified in regulatory documents. It is strictly required that the product not be frozen. The medication must be kept in its original container to protect from light and excessive heat, and the container should be kept tightly closed where applicable. Always keep this medicine out of the sight and reach of children.

Stability and Disposal

Official labeling defines specific stability constraints: for instance, diluted injection solutions must be used within 24 hours, and opened ophthalmic solutions must be discarded after 28 days. Any unused or expired Gentamina must be disposed of in accordance with local requirements. The product must not be disposed of in household waste or wastewater, adhering to pharmaceutical waste protocols.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gentamina found in:

A-Z Index: